A Year In Review
The bispecific field is expanding fast, with 3,162 drugs now in development—a 32% increase from last year. In 2024, clinical momentum surged, with a record 608 new trials initiated, highlighting growing confidence in this space.
This report covers key approvals, emerging trial trends, regulatory updates, and investment shifts, giving you the insights needed to stay ahead.

Download Now
Lead the future of bispecific innovation!
The Review delivers critical insights into the latest innovations, from novel therapeutic formats to strategic industry moves. Explore groundbreaking clinical developments, commercial trends, and the evolving regulatory environment shaping the future of bispecifics.
Report Contents
The Drug Landscape
An overview of clinical entries, discontinuations, and top targets at each phase. Plus insights into new scaffold formats, and emerging therapeutic classes.
The Trial Landscape
A breakdown of 608 new bispecific trials, covering phase distribution, disease indications, and trial locations.
The Commercial Market
2024’s deal and company activity, with a spotlight on the top 10 highest-value deals and emerging industry players.
The Future of Bispecifics
A look ahead at 2025’s potential approvals and the number of trials set to conclude over the next decade, shaping the future of bispecific innovation.
Regulatory Announcements
A summary of 2024’s regulatory updates by type, with a look at the top 5 drugs with the most regulatory activity.
Previous Bispecific Landscape Reviews

ADC 2024 H1 Landscape Review
An analysis of the ADC landscape in H1 of 2024
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements